drugset
drugset / Trial / NCT00523328

BG9924 in Combination With Methotrexate Extension of Study 104RA203 (NCT 00458861)

NCT00523328 ↗

Phase 2 Terminated 72 enrolled Biogen
NaSingle-groupOpen-labelTreatment

Summary

This study is to observe the long-term treatment of BG9924

Timeline

Start
2007-08
Primary completion
2008-10
Completion
2008-10

Outcome

Outcome not reported

Stopped: “Analysis of data from 104RA203 failed to meet primary endpoint.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Baminercept Protein / enzyme biologic — —

Indications

rheumatoid arthritis